Can alprazolam (a benzodiazepine) be used to treat shivering in a patient with fever, potential renal impairment, and gastrointestinal issues?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alprazolam for Shivering: Not Recommended

Alprazolam should not be used to treat shivering. While benzodiazepines like lorazepam and midazolam are mentioned in guidelines for sedation during targeted temperature management, alprazolam is not recommended for shivering control and carries significant risks that outweigh any theoretical benefit 1.

Why Alprazolam Is Not Appropriate

Lack of Guideline Support

  • The American Heart Association guidelines for post-cardiac arrest care specifically recommend opioids as first-line agents for shivering, not benzodiazepines like alprazolam 1.
  • When benzodiazepines are used in shivering management protocols, the guidelines mention lorazepam or midazolam, never alprazolam 1.
  • The European Heart Journal's 2023 sedation and shivering management guidelines do not include alprazolam in their treatment algorithms 1.

Problematic Pharmacology in This Context

  • Alprazolam causes significant sedation and psychomotor impairment, which would confound neurological examination—a critical concern emphasized in guidelines 2, 1.
  • The drug has a 9-16 hour elimination half-life that would be further prolonged in patients with fever, potential renal impairment, and critical illness 3.
  • Renal impairment increases the free fraction of alprazolam in plasma, potentially worsening sedative effects 3.
  • Alprazolam's primary metabolite (lorazepam glucuronide) is renally eliminated, and accumulation could occur with renal dysfunction 4.

Cardiovascular Risks

  • Guidelines emphasize that benzodiazepines can cause hypotension, particularly problematic in patients with fever who may already be hemodynamically compromised 1.
  • The European Heart Journal specifically warns that sedatives can aggravate hemodynamic compromise in patients with shock 1.

Evidence-Based Alternatives for Shivering

First-Line Approach

  • Meperidine 25-50 mg IV is the most effective single agent, stopping shivering in nearly 100% of patients within 5 minutes and is 2,800 times more effective at inhibiting shivering than predicted by analgesic potency alone 5.
  • Surface counterwarming of extremities reduces shivering threshold without sedation 5.
  • NSAIDs (ibuprofen) are preferred initial agents for fever-related shivering 5.

Adjunctive Measures

  • Acetaminophen and magnesium can be used as adjuncts but should not be relied upon alone 1, 5.
  • Buspirone 30 mg every 8 hours can be used preventatively without primary sedation concerns, though it lowers seizure threshold 1, 6.

When Benzodiazepines Are Needed

  • If benzodiazepines are required for sedation during targeted temperature management, use lorazepam or midazolam, not alprazolam 1.
  • These agents should be titrated to minimum effective doses to avoid confounding neurological assessment 1.

Critical Pitfalls to Avoid

  • Do not use alprazolam in elderly patients (>60 years), as benzodiazepines are strongly associated with postoperative cognitive dysfunction and delirium 7.
  • Do not administer any benzodiazepine without considering hemodynamic status, as hypotension is a common adverse effect 1.
  • Do not ignore the underlying cause of fever—rule out sepsis and obtain blood cultures before focusing solely on symptom management 5.
  • Do not use neuromuscular blockers without adequate sedation, as this does not address central thermoregulatory drive 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effect of renal impairment and hemodialysis on lorazepam kinetics.

Clinical pharmacology and therapeutics, 1984

Guideline

Management of Shivering in Fever Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Buspirone Use in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bupivacaine Dosing for Spinal Anesthesia in the Elderly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.